BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28668270)

  • 1. Exogenous fatty acid metabolism in bacteria.
    Yao J; Rock CO
    Biochimie; 2017 Oct; 141():30-39. PubMed ID: 28668270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How bacterial pathogens eat host lipids: implications for the development of fatty acid synthesis therapeutics.
    Yao J; Rock CO
    J Biol Chem; 2015 Mar; 290(10):5940-6. PubMed ID: 25648887
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Zhu L; Zou Q; Cao X; Cronan JE
    mBio; 2019 May; 10(3):. PubMed ID: 31064829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Staphylococcus aureus FASII bypass escape route from FASII inhibitors.
    Morvan C; Halpern D; Kénanian G; Pathania A; Anba-Mondoloni J; Lamberet G; Gruss A; Gloux K
    Biochimie; 2017 Oct; 141():40-46. PubMed ID: 28728970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic basis for the differential susceptibility of Gram-positive pathogens to fatty acid synthesis inhibitors.
    Parsons JB; Frank MW; Subramanian C; Saenkham P; Rock CO
    Proc Natl Acad Sci U S A; 2011 Sep; 108(37):15378-83. PubMed ID: 21876172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acyl-AcpB, a FabT corepressor in
    Lambert C; d'Orfani A; Gaillard M; Zhang Q; Gloux K; Poyart C; Fouet A
    J Bacteriol; 2023 Oct; 205(10):e0027423. PubMed ID: 37811985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid synthesis in Escherichia coli in the absence of phospholipid synthesis and release of inhibition by thioesterase action.
    Jiang P; Cronan JE
    J Bacteriol; 1994 May; 176(10):2814-21. PubMed ID: 7910602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RhlA converts beta-hydroxyacyl-acyl carrier protein intermediates in fatty acid synthesis to the beta-hydroxydecanoyl-beta-hydroxydecanoate component of rhamnolipids in Pseudomonas aeruginosa.
    Zhu K; Rock CO
    J Bacteriol; 2008 May; 190(9):3147-54. PubMed ID: 18326581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental fatty acids enable emergence of infectious Staphylococcus aureus resistant to FASII-targeted antimicrobials.
    Morvan C; Halpern D; Kénanian G; Hays C; Anba-Mondoloni J; Brinster S; Kennedy S; Trieu-Cuot P; Poyart C; Lamberet G; Gloux K; Gruss A
    Nat Commun; 2016 Oct; 7():12944. PubMed ID: 27703138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlamydia trachomatis Scavenges Host Fatty Acids for Phospholipid Synthesis via an Acyl-Acyl Carrier Protein Synthetase.
    Yao J; Dodson VJ; Frank MW; Rock CO
    J Biol Chem; 2015 Sep; 290(36):22163-73. PubMed ID: 26195634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of Exogenous Fatty Acids to Acyl-Acyl Carrier Protein Cannot Bypass FabI Inhibition in Neisseria.
    Yao J; Bruhn DF; Frank MW; Lee RE; Rock CO
    J Biol Chem; 2016 Jan; 291(1):171-81. PubMed ID: 26567338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporation of extracellular fatty acids by a fatty acid kinase-dependent pathway in Staphylococcus aureus.
    Parsons JB; Frank MW; Jackson P; Subramanian C; Rock CO
    Mol Microbiol; 2014 Apr; 92(2):234-45. PubMed ID: 24673884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Staphylococcus aureus Utilizes Host-Derived Lipoprotein Particles as Sources of Fatty Acids.
    Delekta PC; Shook JC; Lydic TA; Mulks MH; Hammer ND
    J Bacteriol; 2018 Jun; 200(11):. PubMed ID: 29581406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidic acid synthesis in bacteria.
    Yao J; Rock CO
    Biochim Biophys Acta; 2013 Mar; 1831(3):495-502. PubMed ID: 22981714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth of
    Zou Q; Dong H; Cronan JE
    mSphere; 2023 Aug; 8(4):e0012023. PubMed ID: 37289195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FadR, transcriptional co-ordination of metabolic expediency.
    Cronan JE; Subrahmanyam S
    Mol Microbiol; 1998 Aug; 29(4):937-43. PubMed ID: 9767562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (p)ppGpp/GTP and Malonyl-CoA Modulate Staphylococcus aureus Adaptation to FASII Antibiotics and Provide a Basis for Synergistic Bi-Therapy.
    Pathania A; Anba-Mondoloni J; Gominet M; Halpern D; Dairou J; Dupont L; Lamberet G; Trieu-Cuot P; Gloux K; Gruss A
    mBio; 2021 Feb; 12(1):. PubMed ID: 33531402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation and characterization of Escherichia coli K-12 mutants lacking both 2-acyl-glycerophosphoethanolamine acyltransferase and acyl-acyl carrier protein synthetase activity.
    Hsu L; Jackowski S; Rock CO
    J Biol Chem; 1991 Jul; 266(21):13783-8. PubMed ID: 1649829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A thioesterase bypasses the requirement for exogenous fatty acids in the plsX deletion of Streptococcus pneumoniae.
    Parsons JB; Frank MW; Eleveld MJ; Schalkwijk J; Broussard TC; de Jonge MI; Rock CO
    Mol Microbiol; 2015 Apr; 96(1):28-41. PubMed ID: 25534847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in inhibitors of bacterial fatty acid synthesis type II (FASII) system enzymes as potential antibacterial agents.
    Wang Y; Ma S
    ChemMedChem; 2013 Oct; 8(10):1589-608. PubMed ID: 23894064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.